(Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 39.38%226.31B | -17.72%430.37B | -30.89%162.36B | 13.01%523.06B | 27.02%234.93B | -4.74%462.86B | -8.44%184.96B | 28.18%485.91B | 53.16%202.01B | 67.07%379.08B |
Operating income | 39.38%226.31B | -17.72%430.37B | -30.89%162.36B | 13.01%523.06B | 27.02%234.93B | -4.74%462.86B | -8.44%184.96B | 28.18%485.91B | 53.16%202.01B | 67.07%379.08B |
Cost of sales | -72.63%-250.57B | 7.62%-397.49B | 23.06%-145.15B | -18.88%-430.28B | -34.68%-188.65B | -0.75%-361.95B | 4.81%-140.07B | -29.89%-359.27B | -51.82%-147.15B | -64.53%-276.6B |
Operating expenses | -72.63%-250.57B | 7.62%-397.49B | 23.06%-145.15B | -18.88%-430.28B | -34.68%-188.65B | -0.75%-361.95B | 4.81%-140.07B | -29.89%-359.27B | -51.82%-147.15B | -64.53%-276.6B |
Gross profit | -240.98%-24.26B | -64.56%32.88B | -62.82%17.21B | -8.05%92.78B | 3.11%46.28B | -20.32%100.91B | -18.17%44.89B | 23.58%126.64B | 56.85%54.86B | 74.32%102.48B |
Selling expenses | -45.09%-6.64B | 26.23%-11.3B | 40.58%-4.58B | -11.37%-15.32B | -11.69%-7.7B | 15.97%-13.75B | 24.23%-6.89B | -30.58%-16.37B | -102.09%-9.1B | -25.30%-12.53B |
Administrative expenses | 24.88%-3.22B | 37.58%-8.44B | 31.03%-4.29B | 2.88%-13.52B | 5.49%-6.21B | 20.64%-13.92B | 31.31%-6.57B | -5.64%-17.54B | -88.81%-9.57B | -99.99%-16.6B |
Research and development expenses | 27.72%-704M | 34.58%-2.16B | 24.55%-974M | -24.88%-3.31B | -25.34%-1.29B | -34.26%-2.65B | -66.13%-1.03B | -61.19%-1.97B | -87.31%-620M | ---1.22B |
Revaluation surplus | -772.92%-838M | 48.46%-117M | -100.00%-96M | -1,846.15%-227M | -1,700.00%-48M | -89.68%13M | -81.25%3M | -92.73%126M | -97.03%16M | 243.16%1.73B |
-Changes in the fair value of investment property | -772.92%-838M | 48.46%-117M | -100.00%-96M | -1,846.15%-227M | -1,700.00%-48M | -89.68%13M | -81.25%3M | -92.73%126M | -97.03%16M | 243.16%1.73B |
Impairment and provision | -2,105.96%-6.66B | -85.28%-3.06B | 45.19%-302M | -13.94%-1.65B | 35.48%-551M | 4.36%-1.45B | 12.23%-854M | -28.83%-1.52B | -101.87%-973M | ---1.18B |
-Other impairment is provision | -2,105.96%-6.66B | -85.28%-3.06B | 45.19%-302M | -13.94%-1.65B | 35.48%-551M | 4.36%-1.45B | 12.23%-854M | -28.83%-1.52B | -101.87%-973M | ---1.18B |
Special items of operating profit | -4,477.27%-2.89B | -183.38%-1.37B | -96.20%66M | -41.87%1.64B | -7.50%1.74B | -14.36%2.82B | 13.53%1.88B | -24.31%3.29B | -5.80%1.66B | 66.34%4.34B |
Operating profit | -741.87%-45.21B | -89.33%6.44B | -78.14%7.04B | -16.07%60.4B | 2.55%32.22B | -22.33%71.97B | -13.37%31.42B | 20.31%92.66B | 34.89%36.27B | 76.65%77.02B |
Financing income | 68.33%1.58B | -6.59%3.57B | -56.85%941M | -47.93%3.82B | -13.04%2.18B | 209.74%7.34B | 66.53%2.51B | -3.03%2.37B | 93.82%1.51B | -28.56%2.45B |
Financing cost | 32.22%-3.04B | -2,462.39%-8.38B | -1,512.23%-4.48B | -760.53%-327M | 55.31%-278M | 96.83%-38M | -3.49%-622M | -9.39%-1.2B | -0.84%-601M | -648.47%-1.1B |
Share of profit from joint venture company | -72.02%519M | -26.26%3.73B | -40.58%1.86B | -19.26%5.05B | 20.87%3.12B | 22.51%6.26B | 11.48%2.58B | 326.73%5.11B | 1,203.33%2.32B | --1.2B |
Earning before tax | -961.29%-46.15B | -92.22%5.36B | -85.61%5.36B | -19.39%68.95B | 3.78%37.25B | -13.55%85.53B | -9.12%35.89B | 24.35%98.94B | 47.03%39.49B | 71.02%79.56B |
Tax | -53.96%-5.31B | 70.24%-8.32B | 76.72%-3.45B | 10.96%-27.97B | -6.19%-14.83B | 16.76%-31.41B | 15.03%-13.96B | -21.65%-37.74B | -55.92%-16.43B | -74.57%-31.02B |
After-tax profit from continuing operations | -2,798.53%-51.46B | -107.23%-2.96B | -91.49%1.91B | -24.27%40.98B | 2.25%22.42B | -11.57%54.12B | -4.91%21.93B | 26.08%61.2B | 41.29%23.06B | 68.83%48.54B |
Earning after tax | -2,798.53%-51.46B | -107.23%-2.96B | -91.49%1.91B | -24.27%40.98B | 2.25%22.42B | -11.57%54.12B | -4.91%21.93B | 26.08%61.2B | 41.29%23.06B | 68.83%48.54B |
Minority profit | -295.29%-2.53B | -78.22%3.09B | -82.56%1.3B | -25.72%14.19B | -4.75%7.42B | -11.80%19.1B | 5.01%7.79B | 55.50%21.65B | 119.59%7.42B | 417.95%13.92B |
Profit attributable to shareholders | -8,095.42%-48.93B | -122.58%-6.05B | -95.92%612M | -23.49%26.8B | 6.11%15B | -11.45%35.02B | -9.61%14.13B | 14.25%39.55B | 20.84%15.64B | 32.82%34.62B |
Dividend | ---- | ---- | ---- | -57.46%2.34B | 4.15%4.72B | -26.48%5.51B | -8.58%4.53B | 14.16%7.49B | 23.30%4.95B | 21.00%6.56B |
Basic earnings per share | -6,066.67%-1.79 | -121.31%-0.26 | -95.65%0.03 | -24.69%1.22 | 4.55%0.69 | -12.43%1.62 | -9.59%0.66 | 14.91%1.85 | 21.67%0.73 | 31.11%1.61 |
Diluted earnings per share | -6,066.67%-1.79 | -121.49%-0.26 | -95.59%0.03 | -22.93%1.21 | 7.94%0.68 | -12.29%1.57 | -11.27%0.63 | 15.48%1.79 | 22.41%0.71 | 26.57%1.55 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data